• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Gardner Denver Acquires Oina

Share:

July 15, 2019

Acquisition of Oina will provide further access to the peristaltic pumps market and enhanced R&D capabilities and leverage Gardner Denver’s distribution network, commercial, and operational capabilities
Acquisition fits disciplined capital allocation strategy of M&A in mission-critical technologies with strong aftermarket potential

MILWAUKEE–(BUSINESS WIRE)– Gardner Denver Holdings, Inc. (NYSE: GDI), a leading global provider of mission-critical flow control and compression equipment, announced that it has acquired Oina VV AB, for a net purchase price of approximately $10 million funded by cash on hand. Based in Stockholm, Sweden, Oina specializes in customized pump solutions for liquid handling processes for use in medical, process and industrial applications. Oina will be part of Gardner Denver’s Medical Segment.

“Oina has a strong history of delivering innovative products and building excellent customer relationships. This acquisition complements and expands our existing peristaltic pump offering and provides increased access to and expertise in the market,” said Vicente Reynal, Gardner Denver’s CEO. “This is another important step in our strategy to drive ongoing profitable growth by leveraging core, mission-critical technologies in attractive end markets.”

The CEO of Oina, Anders Lovas, stated, “We are excited to join the Gardner Denver family. Oina will be able to leverage an expanded commercial and operational footprint as we continue to innovate and deliver high quality products and service to our customers.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934. These statements include, but are not limited to, statements related to our expectations regarding the performance of our business, our financial results, our liquidity and capital resources and other non-historical statements. You can identify these forward-looking statements by the use of words such as “outlook,” “guidance,” “believes,” “expects,” “potential,” “continues,” “may,” “will,” “should,” “could,” “seeks,” “projects,” “predicts,” “intends,” “plans,” “estimates,” “anticipates” or the negative version of these words or other comparable words. Such forward-looking statements are subject to various risks and uncertainties, including macroeconomic factors beyond the Company’s control, risks of doing business outside the United States, the Company’s dependence on the level of activity in the energy industry, potential governmental regulations restricting the use of hydraulic fracturing, raw material costs and availability, the risk of a loss or reduction of business with key customers or consolidation or the vertical integration of the Company’s customer base, loss of or disruption in the Company’s distribution network, the risk that ongoing and expected restructuring plans may not be as effective as the Company anticipates, and the Company’s substantial indebtedness. Additional factors that could cause Gardner Denver’s results to differ materially from those described in the forward-looking statements can be found under the section entitled “Risk Factors” in our most recent annual report on form 10-K filed with the Securities and Exchange Commission (“SEC”), as such factors may be updated from time to time in our periodic filings with the SEC, which are accessible on the SEC’s website at www.sec.gov. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in our filings with the SEC. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law.

Date: July 15, 2019

Source: Gardner Denver

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Pinterest Adds Tools to Help Users Deal with Mental StressPinterest Adds Tools to Help Users Deal with Mental Stress
  • Here are 6 major issues facing healthcare in 2019, according to PwCHere are 6 major issues facing healthcare in 2019, according to PwC
  • AppliedVR Lands $29M for VR Platform to Treat Chronic PainAppliedVR Lands $29M for VR Platform to Treat Chronic Pain
  • SI Group Announces Focused Sale Of Industrial Resin Business to ASK ChemicalsSI Group Announces Focused Sale Of Industrial Resin Business to ASK Chemicals
  • Whole Slide Imaging Market to Grow at 17% CAGR from 2022 to 2030; Rising Usage of Whole Slide Imaging in Drug Discovery Process to Usher Growth: The Brainy InsightsWhole Slide Imaging Market to Grow at 17% CAGR from 2022 to 2030; Rising Usage of Whole Slide Imaging in Drug Discovery Process to Usher Growth: The Brainy Insights
  • Pasha Brands Acquires Health Canada Approved Processor and CultivatorPasha Brands Acquires Health Canada Approved Processor and Cultivator
  • PharmaDrug Completes Acquisition of Sairiyo Therapeutics Inc.PharmaDrug Completes Acquisition of Sairiyo Therapeutics Inc.
  • Ruth Health Scores $2.4M for Pregnancy, Postpartum SupportRuth Health Scores $2.4M for Pregnancy, Postpartum Support

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications